Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
Osteogenesis imperfecta (OI) is a genetic bone pathology with prenatal onset, characterized by brittle bones in response to abnormal collagen composition. There is presently no cure for OI. We previously showed that human first trimester fetal blood mesenchymal stem cells (MSCs) transplanted into a...
Main Authors: | Jones, G, Moschidou, D, Abdulrazzak, H, Kalirai, B, Vanleene, M, Osatis, S, Shefelbine, S, Horwood, N, Marenzana, M, De Coppi, P, Bassett, J, Williams, G, Fisk, N, Guillot, P |
---|---|
格式: | Journal article |
语言: | English |
出版: |
2014
|
相似书籍
-
Ontological differences in first compared to third trimester human fetal placental chorionic stem cells
由: Jones, G, et al.
出版: (2012) -
Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties.
由: Vanleene, M, et al.
出版: (2011) -
Ontological differences in first compared to third trimester human fetal placental chorionic stem cells.
由: Gemma N Jones, et al.
出版: (2012-01-01) -
Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice.
由: Guillot, P, et al.
出版: (2008) -
Structure–mechanics relationships of collagen fibrils in the osteogenesis imperfecta mouse model
由: Andriotis, O. G., et al.
出版: (2016)